Literature DB >> 9102729

Differentiated perceptual evaluation of pathological voice quality: reliability and correlations with acoustic measurements.

P H Dejonckere1, M Remacle, E Fresnel-Elbaz, V Woisard, L Crevier-Buchman, B Millet.   

Abstract

The perceptual GRBAS scale for deviant voice quality (completed with a "I" parameter: Instability = fluctuation of voice quality over time) was tested in 5 different institutes on 943 voice patients. Each voice was evaluated separately by 2 professionals. The interrater correlation reaches 0.87 for G (grade), 0.70 for R (roughness), 0.69 for B (breathiness) and 0.65 for A/S (asthenicity/strain). Experience with the scale significantly improves the interrater agreement. The intrarater correlation (80 voices; time interval 2-6 months) is systematically slightly stronger than the interrater correlation. Further, GIRBAS/acoustical correlations were investigated on 80 pathological voices, by using the Multidimensional Voice Program (MDVP) of Kay. Principal component analysis allows reduction of 21 MDVP parameters to 5 clinically relevant aspects, with a typical acoustical measurement for each of them. The strongest correlations are found between G and Shimmer/Noise to harmonics ratio, R and Jitter, and B and Shimmer. As tremor and diplophonia are easily identified perceptually and acoustically, it seems useful to add this information respectively to AS and R. The GIRBAS scale seems to be a valuable instrument for clinical practice.

Entities:  

Mesh:

Year:  1996        PMID: 9102729

Source DB:  PubMed          Journal:  Rev Laryngol Otol Rhinol (Bord)        ISSN: 0035-1334


  30 in total

1.  The reliability of three perceptual evaluation scales for dysphonia.

Authors:  A L Webb; P N Carding; I J Deary; K MacKenzie; N Steen; J A Wilson
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-11-13       Impact factor: 2.503

2.  Swallowing, speech and quality of life in patients undergoing resection of soft palate.

Authors:  Lívia Fernandes Barata; Genival Barbosa de Carvalho; Elisabete Carrara-de Angelis; José Carlos Marques de Faria; Luiz Paulo Kowalski
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-04-22       Impact factor: 2.503

3.  Effects of age on the amplitude, frequency and perceived quality of voice.

Authors:  Catherine L Lortie; Mélanie Thibeault; Matthieu J Guitton; Pascale Tremblay
Journal:  Age (Dordr)       Date:  2015-11-14

4.  [Does the subjective assessment of roughness correlate with a computer-aided measurement of irregularity index?].

Authors:  M Ptok; C Iven; M Jessen; C Schwemmle
Journal:  HNO       Date:  2006-02       Impact factor: 1.284

5.  [On the auditory evaluation of voice quality].

Authors:  M Ptok; C Schwemmle; C Iven; M Jessen; T Nawka
Journal:  HNO       Date:  2006-10       Impact factor: 1.284

6.  Perceptual evaluation of substitution voices: development and evaluation of the (I)INFVo rating scale.

Authors:  M B J Moerman; J P Martens; M J Van der Borgt; M Peleman; M Gillis; P H Dejonckere
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-06-25       Impact factor: 2.503

7.  Effectiveness of laryngostroboscopy for monitoring the evolution of functional dysphonia after rehabilitator treatment.

Authors:  Wasim Elhendi Halawa; Irene Vázquez Muñoz; Sofía Santos Perez
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-03-12

8.  The effect of electrolyte balance on the voice in hemodialysis patients.

Authors:  Saime Sagiroglu; Adem Doganer
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-08-21       Impact factor: 2.503

9.  The Perception of Breathiness in the Voices of Pediatric Speakers.

Authors:  Lisa M Kopf; Mark D Skowronski; Supraja Anand; David A Eddins; Rahul Shrivastav
Journal:  J Voice       Date:  2017-11-20       Impact factor: 2.009

10.  Spasmodic dysphonia, perceptual and acoustic analysis: presenting new diagnostic tools.

Authors:  Denise Irene Siemons-Lühring; Mieke Moerman; Jean-Pierre Martens; Dirk Deuster; Frank Müller; Philippe Dejonckere
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-12       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.